Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study Osteosarcoma (OS) is the most ...

Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC. Results for miRNA-only XGBoost algorithm in held-out ...

The XGBoost-based approach demonstrated robust external validation across multiple centers, supporting clinical adoption to guide personalized treatment decisions.

Anyone waiting for the results of a medical test knows the anxious question:'Will my life change completely when I know?' And the relief if you test negative. Nowadays, Artificial Intelligence (AI) is ...